NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹16 Cr | ₹7.22 Cr | ₹7.61 Cr | ₹10 Cr | ₹12 Cr |
What is the latest Long Term Provisions ratio of NEULAND LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹16 Cr |
| Mar2025 | ₹7.22 Cr |
| Mar2024 | ₹7.61 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹12 Cr |
How is Long Term Provisions of NEULAND LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹16 Cr | 119.62 | |
| Mar2025 | ₹7.22 Cr | -5.10 | |
| Mar2024 | ₹7.61 Cr | -26.05 | |
| Mar2023 | ₹10 Cr | -13.62 | |
| Mar2022 | ₹12 Cr | - | |
Compare Long Term Provisions of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹30,159.6 Cr | 0.3% | 23.3% | 79.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0.3% |
23.3% |
79.4% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses